🔥🐔 BizChicken 🐔🔥
Companies Similar to Atara Biotherapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Anixa Biosciences, Inc.
Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines
Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.
Symbol: ANIX
Recent Price: $2.50
Industry: Biotechnology
CEO: Dr. Amit Kumar Ph.D.
Sector: Healthcare
Employees: 4
Address: 3150 Almaden Expressway, San Jose, CA 95118
Phone: 408 708 9808
Last updated: 2024-12-31
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Applied Therapeutics, Inc.
AT-007
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.
About | Leadership | Leadership | Leadership | Leadership | Vision/Values | Culture | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: APLT
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Sector: Healthcare
Employees: 31
Address: 545 Fifth Avenue, New York, NY 10017
Phone: 212 220 9226
Leadership
- Shoshana Shendelman, Chair, Board of Directors
- Riccardo Perfetti, Chief Medical Officer
- Les Funtleyder,
- Dale Hooks, Chief Commercial Officer
- Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
- Joel Marcus,
- Jay Skyler,
- Stacy Kanter,
- Teena Lerner,
- Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
- Roy Freeman M.D.,
- Roxana Mehran M.D.,
- Lawrence Steinman M.D.,
- Gregg Stone M.D.,
- Donald d'Amico M.D.,
- Donald Landry, Chair, Scientific Advisory Board
- Roy Freeman,
- Roxana Mehran,
- Lawrence Steinman,
- Gregg Stone,
- Donald d'Amico,
Last updated: 2024-12-31
Atea Pharmaceuticals, Inc.
AT-527
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics for viral infections, with a lead product candidate AT-527 for COVID-19 treatment.
Symbol: AVIR
Recent Price: $3.33
Industry: Biotechnology
CEO: Dr. Jean-Pierre Sommadossi Ph.D.
Sector: Healthcare
Employees: 75
Address: 125 Summer Street, Boston, MA 02110
Phone: 857 284 8891
Leadership
- Jean-Pierre Sommadossi, PhD, FOUNDER, CHAIRMAN & CEO
- Nancy Agrawal, PhD, Executive VP, Preclinical Development
- Jonae Barnes, Senior VP, Investor Relations & Corporate Communications
- Bruce Belanger, PhD, Senior VP, Biostatistics
- Andrea Corcoran, CFO & Executive VP, Legal
- Adam DeZure, MD, VP, Clinical Development
- James MB Evans, PhD, VP, CMC Manufacturing
- Wayne Foster, EXECUTIVE VP, Chief Accounting Officer
- Kerry Gagnon, VP, Head of Quality
- Steven Good, EXECUTIVE VP, PRECLINICAL SCIENCE
- Janet Hammond, MD, PhD, CHIEF DEVELOPMENT OFFICER
- Arantxa Horga, MD, Chief Medical Officer
- Qi Huang, Senior VP, Virology
- Laura Ishak, Senior VP, Clinical Operations
- Ariyapadi Krishnaraj, VP, Marketing
- Adel Moussa, PhD, EXECUTIVE VP, CHEMISTRY
- Shari Noble, VP, Deputy General Counsel
- Keith Pietropaolo, Executive VP, Clinical Sciences and Project Management
- Brian Rowe, VP, Business Development
- Marc Van Hulle, VP, Finance
- John Vavricka, CHIEF COMMERCIAL OFFICER
- Alex Vo, PhD, VP, DMPK
- Jayanthi Wolf, PhD, Executive VP, Regulatory Affairs
- Xiao-Jian Zhou, PhD, EXECUTIVE VP, EARLY STAGE DEVELOPMENT
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Vera Therapeutics, Inc.
atacicept
Vera Therapeutics, Inc. is a clinical stage biotechnology company focusing on developing and commercializing treatments for serious immunological diseases, including atacicept for immunoglobulin A nephropathy and MAU868 for BK viremia infections.
Careers | About | About | About | About | Contact | Careers | Careers | Jobs | About | About | Jobs | Careers
Symbol: VERA
Recent Price: $42.06
Industry: Biotechnology
CEO: Dr. Marshall W. Fordyce M.D.
Sector: Healthcare
Employees: 72
Address: 8000 Marina Boulevard, Brisbane, CA 94005
Phone: 650 770 0077
Last updated: 2024-12-31
Allogene Therapeutics, Inc.
UCART19
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.
About | About | About | Contact | Contact | Careers | Careers | Jobs | About | About | About | About | About | About
Symbol: ALLO
Recent Price: $2.10
Industry: Biotechnology
CEO: Dr. David D. Chang M.D., Ph.D.
Sector: Healthcare
Employees: 232
Address: 210 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 457 2700
Last updated: 2024-12-31
Atara Biotherapeutics, Inc.
T-cell immunotherapy treatments
Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.
About | About | About | Contact | About | Careers | Careers | About | Careers | Careers | About | About
Symbol: ATRA
Recent Price: $13.28
Industry: Biotechnology
CEO: Dr. Anhco Nguyen Ph.D.
Sector: Healthcare
Employees: 165
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 650 278 8930
Last updated: 2024-12-31
Biora Therapeutics, Inc.
oral biotherapeutics
Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.
About | Leadership | About | Contact | Contact | Careers | Careers | About | Careers | Careers | About | About
Symbol: BIOR
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Aditya P. Mohanty M.B.A.
Sector: Healthcare
Employees: 58
Address: 4330 La Jolla Village Drive, San Diego, CA 92122
Phone: 855 293 2639
Leadership
- Adi Mohanty, MBA, Chief Executive Officer & Board Member
- Eric d’Esparbes, Chief Financial Officer
- Robyn Hatton, Head of Human Resources
- Ariella Kelman, MD, Chief Medical Officer
- James Knight, MBA, Head of Business Development
- Clarke Neumann, JD, General Counsel and Secretary
- Paul Shabram, MBA, Head of Technical Operations
- Sharat Singh, PhD, Head of Research
- Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
- Jeffrey Alter, MBA, Board Chair
- Jeffrey Ferrell, Board Member
- Jill Howe, Board Member
- Brian Kotzin, MD, Board Member
- Lynne Powell, MBA, Board Member
- Bruce Sands, MD, MS, Advisory Board Chair
- Geert D’Haens, MD, PhD, Advisory Board Member
- Brian Feagan, MD, FRCPC, Advisory Board Member
- Séverine Vermeire, MD, PhD, Advisory Board Member
- Satish Rao, MD, PhD, Advisory Board Chair
- William Chey, MD, Advisory Board Member
- Anthony Lembo, MD, Advisory Board Member
- Mark Pimentel, MD, Advisory Board Member
Last updated: 2024-12-31
Indaptus Therapeutics, Inc.
Decoy20
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.
Symbol: INDP
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. Jeffrey A. Meckler
Sector: Healthcare
Employees: 7
Address: 3 Columbus Circle, New York, NY 10019
Phone: 347 480 9760
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Protara Therapeutics, Inc.
N/A
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
No tags available.
Symbol: TARA
Recent Price: $5.28
Industry: Biotechnology
CEO: Mr. Jesse Shefferman
Sector: Healthcare
Employees: 26
Address: 345 Park Avenue South, New York, NY 10010
Phone: 646 844 0337
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
TScan Therapeutics, Inc.
T cell receptor-engineered T cell therapies
TScan Therapeutics, Inc. is a preclinical-stage biopharmaceutical company that develops T cell receptor-engineered T cell therapies for cancer treatment. It is working on therapies for hematologic malignancies and solid tumors, as well as vaccines for infectious diseases like SARS-CoV-2.
About | About | Management | Directors | About | About | Contact | Careers | Careers | Careers | About | About
Symbol: TCRX
Recent Price: $3.00
Industry: Biotechnology
CEO: Dr. Gavin MacBeath Ph.D.
Sector: Healthcare
Employees: 175
Address: 830 Winter Street, Waltham, MA 02451
Phone: 857 399 9500
Leadership
- Stephen Biggar, M.D., Ph.D., Partner at Baker Bros. Advisors LP
- Katina Dorton, J.D., M.B.A., CFO of Nodthera
- Gabriela Gruia, M.D., Chief Development Officer at Ichnos Sciences
- Barbara Klencke, M.D., Former Chief Medical Officer and Chief Development Officer of Sierra Oncology Inc.
- Gavin MacBeath, Ph.D., CEO of TSCAN
- Garry Nicholson, Former President of Pfizer Oncology
- R. Keith Woods, Former Chief Operating Officer of argenx
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Arcus Biosciences, Inc.
Cancer Therapies
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.
About | About | Leadership | Directors | About | Contact | Contact | Contact | Contact | Contact | Careers | About | About | About | About | Careers | About | Jobs | About | About
Symbol: RCUS
Recent Price: $14.91
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Sector: Healthcare
Employees: 577
Address: 3928 Point Eden Way, Hayward, CA 94545
Phone: 510 694 6200
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Marker Therapeutics, Inc.
Multi TAA-specific T cell technology
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing T cell-based immunotherapies and peptide-based vaccines for treating hematological malignancies and solid tumors in the US.
Contact | About | Management | Directors | About | Contact | Contact | Careers | About | About
Symbol: MRKR
Recent Price: $3.34
Industry: Biotechnology
CEO: Dr. Juan F. Vera M.D.
Sector: Healthcare
Employees: 8
Address: 3200 Southwest Freeway, Houston, TX 77027
Phone: 713 400 6400
Leadership
- David Eansor, President, Protein Sciences Segment, Bio-Techne Corporation
- Steve Elms, Managing Partner, Aisling Capital
- John R. Wilson, CEO, Wilson Wolf Manufacturing, Co-Founder Marker Therapeutics, Co-Founder AlloVir
- Juan F. Vera, Chief Executive Officer & Co-Founder, Marker Therapeutics, Co-Founder, AlloVir
- Katharine Knobil, M.D., Chief Medical Officer at Agilent Technologies, Inc.
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31